Rho Activator II
Product Uses Include
- Activator for Rho pathway
- Study the effects of Rho activation on cell motility
- Study the effects of Rho activation on the rearrangement of the actin cytoskeleton
- Investigate the effects of Rho activation with respect to cross talk with other signal transduction pathways
The G-switch™ Direct Modulators have been developed with an emphasis on creating highly potent cell permeable reagents that directly target the Rho family of small G-proteins. Our Direct Activator reagents are based on the catalytic domain of the bacterial CNF toxins, which are covalently attached to a proprietary cell penetrating moiety. Rho Activator II (Cat# CN03) enters the cell and activates Rho GTPase isoforms by deamidating glutamine-63, which is located in the Switch II region of these GTPases (1). This modification converts glutamine-63 to glutamate, which blocks intrinsic and GAP stimulated GTPase activity resulting in constitutively active Rho (2). Rho Activator II robustly increases the level of GTP bound RhoA within 2-4 h after addition to the culture medium, providing a more rapid alternative to transfection based methods for introducing activators like GEFs into cells. Moreover, the targeted action of Rho Activator II makes it far more attractive tool for the study of Rho GTPase signaling than classic indirect activators (e.g. LPA) that concomitantly activate other signaling pathways (e.g. Ras, PI3K and PLC).
- Schmidt, G., et al., Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature, 1997. 387(6634): p. 725-9.
- Flatau, G., et al., Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature, 1997. 387(6634): p. 729-33.
For product Datasheets and MSDSs please click on the PDF links below. For additional information, click on the FAQs tab above or contact our Technical Support department at firstname.lastname@example.org
Iyer et al., 2012. Connective tissue growth factor-mediated upregulation of neuromedin-U expression in trabecular meshwork cells and its role in homeostasis of aqueous humor outflow. Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.12-9681.
Kuang et al., 2012. Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells. Circ. Res. v 110, pp 1411-1422.
Question 1: Can the direct Rho activator CN03 be used with cells growing in culture?
Answer 1: Yes, CN03 is specifically designed to be used as a Rho activator with cultured cells. The active site of CN03 is based on the catalytic domain of the bacterial cytotoxic necrotizing factor (CNF) toxins. The catalytic domain of CN03 is covalently attached to a proprietary cell penetrating moiety. Upon entry into the cell, CN03 activates Rho GTPase isoforms by deamidating glutamine-63, which is located in the Switch II region of these GTPases. This modification converts glutamine-63 to glutamate, which blocks intrinsic and GAP-stimulated GTPase activity, resulting in constitutively active Rho. CN03 robustly increases the level of GTP-bound RhoA within 2-4 h after addition to the culture medium.
Question 2: How can I assess whether Rho activity is changing in my cells following CN03 treatment?
Answer 2: There are multiple ways to measure changes in Rho activity. To visualize a change in Rho activity, we recommend examining Rho-mediated stress fiber formation with fluorescently-labeled phalloidin (Cat. # PHDG1, PHDH1, PHDN1, PHDR1). These Acti-stain phalloidins label F-actin stress fibers. Activation of Rho can be directly quantified with one of our activation assays, either the traditional pull-down (Cat. # BK036) or the RhoA G-LISA activation assay (Cat. # BK124).
If you have any questions concerning this product, please contact our Technical Service department at email@example.com.
- New Products
- Actin Products
- Activation Assays
- Custom Services
- ECM Proteins
- HTS & Bulk
- Kits & Assays
- Motor Proteins
- Other Proteins
- Small G-proteins
- Tubulin & FtsZ Products
You have no items in your shopping cart.
You have no items to compare.
5/3/13Life Inside a Microtubule Read more
3/31/13Tau PTMs as Therapeutic Targets Read more